NDC 0002-7752-01 - Insulin Lispro
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0002-7752
- Requested NDC
- 0002-7752-01
- Package NDCs from labels
- 0002-7752-01, 0002-7752-05
- Manufacturer
- Eli Lilly and Company
- Effective date
- 2025-06-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Insulin Lispro - Eli Lilly and Company | Eli Lilly and Company | 2025-06-17 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0002-7752-05 | 2024-01-30 | C162847 | 48780-1 | 1030e365-2939-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use INSULIN LISPRO safely and effectively. See full prescribing information for INSULIN LISPRO. INSULIN LISPRO injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996 This product is HUMALOG ® (insulin lispro). |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0002-7752-01 | Insulin Lispro Junior KwikPen | 3 mL in 1 SYRINGE | INJECTION, SOLUTION | 3 | 12 | |
| 0002-7752-05 | Insulin Lispro Junior KwikPen | 5 in 1 CARTON | INJECTION, SOLUTION | 5 | 12 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0002-7752 | INSULIN LISPRO INJECTION, SOLUTION INSULIN LISPRO KWIKPEN (INSULIN LISPRO) INJECTION, SOLUTION INSULIN LISPRO JUNIOR KWIKPEN (INSULIN LISPRO) INJECTION, SOLUTION [ELI LILLY AND COMPANY] | 11 | Current NDC, Legacy NDC, 2 package rows | 20241213_97d5e596-aae1-42c9-ae89-c3780959c467.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0002-7752-01 | ML - Milliliter | 0002-7752 | a33dea4a-34d3-4aad-aee0-7ec8c9287ae0 | 1 | 2020-04-20 |
| 0002-7752-05 | ML - Milliliter | 0002-7752 | 4b567318-1ca3-4059-a4dc-299cfcce16c3 | 1 | 2020-04-20 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cold Sore Fast-Acting Pain Relief | GLYCERIN AND LIDOCAINE | Blistex Inc. | c7511322-dd6c-441c-bf7d-ad4f0c14956a | 2025-07-22 | Warnings | PDC6A3C0OX |
| Cureforte Breath Reset | MOUTH SPRAY | STEEL CITY HEALTH PRIVATE LIMITED | 38ddf1a7-29ab-cb8d-e063-6294a90ad34c | 2025-07-21 | Warnings | PDC6A3C0OX |
| GoodSense Hemorrhoidal Pain Relief | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | Perrigo Direct, Inc | 2e5f699d-45e8-6451-e063-6394a90a8ad8 | 2025-07-20 | Warnings | PDC6A3C0OX |
| SilkTears | GLYCERIN OPHTHALMIC SOLUTION | SilkTears | 3866e2c1-051b-0b01-e063-6394a90af5cf | 2025-07-16 | Warnings | PDC6A3C0OX |
| Rena-Chord | HOMEOPATHIC LIQUID | Energetix Corporation | 4071f90a-8a28-4338-810b-c9b18cf32f87 | 2025-07-15 | Warnings | J41CSQ7QDS |
| DENTAL-CHORD | ACETICUM ACIDUM, AMMONIUM MURIATICUM, ARGENTUM METALLICUM, AURUM METALLICUM, CALCAREA FLUORICA, CALCAREA PHOSPHORICA, CARBOLICUM ACIDUM, CITRUS LIMONUM, CUPRUM METALLICUM, FERRUM METALLICUM, GLYCYRRHIZA GLABRA, LAPPA MAJOR, MEDULLA OSSIS SUIS, MERCURIUS SOLUBILIS, MYRRHA, NATRUM FLUORATUM, PALLADIUM METALLICUM, PHOSPHORICUM ACIDUM, PHYTOLACCA DECANDRA, SELENIUM METALLICUM, SILICEA, STANNUM METALLICUM, STAPHYSAGRIA, STILLINGIA SYLVATICA, TRIFOLIUM PRATENSE, X-RAY, ZINCUM OXYDATUM | Energetix Corporation | 6c9ba926-7c35-49fd-94d8-988ca0bb772c | 2025-07-15 | Warnings | 339NCG44TV |
| Nikzon Hemorrhoidal | GLYCERIN, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE, AND PRAMOXINE HYDROCHLORIDE | Genomma Lab USA | 8f9a9939-2c99-489f-b597-9a51ec2684f9 | 2025-07-14 | Warnings | PDC6A3C0OX |
| Sterile Water | STERILE WATER | Nephron Pharmaceuticals Corporation | bc04a883-babc-87a6-e053-2995a90a3dfd | 2025-07-11 | Warnings, Adverse reactions | 059QF0KO0R |
| Maximum Strength Hemorrhoidal Cream with Aloe | GLYCERIN, PHENYLEPHINE HCI, PRAMOXINE HCI, PETROLATUM | Chain Drug Marketing Association | 396ea654-8be1-591a-e063-6294a90a11e2 | 2025-07-08 | Warnings | PDC6A3C0OX |
| Rexall Ready to use 4pk LAXATIVE | SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Dolgencorp, LLC | 78509915-0ef1-4238-99a5-78a49a68f98f | 2025-07-07 | Warnings | GR686LBA74 |
| Hemorrhoidal Cream | GLYCEROL, PHENYLEPHINE, PRAMOXINE, PETROLATUM | Trifecta Pharmaceuticals Usa Llc | 38cf4e43-280b-eb96-e063-6294a90a5949 | 2025-07-02 | Warnings | PDC6A3C0OX |
| SEFUDUN FUNGAL NAIL PATCHES | GLYCERIN | Shenzhen Shandian Jingling Technology Co., Ltd. | 38db97d6-27c8-da99-e063-6294a90aac66 | 2025-07-01 | Warnings | PDC6A3C0OX |
| InterSol | PLATELET ADDITIVE 3 | Fenwal, Inc. | 17dec820-1b57-4ac9-82a8-419cab664a2f | 2025-06-27 | Warnings, Adverse reactions | GR686LBA74 |
| Glycerin Laxative | GLYCERIN LAXATIVE SUPPOSITORIES | Neilmed Pharmaceuticals Inc. | 35cc266a-196f-16ce-e063-6394a90a24af | 2025-06-20 | Warnings | PDC6A3C0OX |
| Plaque identifying | PLAQUE IDENTIFYING | Shenzhen Yagao Technology Co., Ltd. | 37eeb656-22f1-7372-e063-6394a90ad041 | 2025-06-19 | Warnings | 059QF0KO0R |
| Saline Laxative | SODIUM PHOSPHATE | Walgreen Company | fb260df0-7bda-4299-84a5-44c8f9447798 | 2025-06-18 | Warnings | GR686LBA74 |
| Insulin Lispro | INSULIN LISPRO | Eli Lilly and Company | 97d5e596-aae1-42c9-ae89-c3780959c467 | 2025-06-17 | Warnings, Adverse reactions | BLA020563 0002-7752-05 0002-8222-01 0002-8222-59 0002-7737-01 0002-7752-01 0002-8222 0002-7737 0002-7752 00002775201 1652639 1926331 242120 6329aa6b-3571-4196-83b0-fc99de56f3ab 97d5e596-aae1-42c9-ae89-c3780959c467 GFX7QIS1II |
| QUALITY CHOICE Sore Throat | PHENOL | CHAIN DRUG MARKETING ASSOCIATION | c95ee086-f384-475d-ad0c-75518cb9d2fe | 2025-06-10 | Warnings | 339NCG44TV |
| ADMELOG | INSULIN LISPRO | Sanofi-Aventis U.S. LLC | 0691def8-4a7b-4de3-866f-a280989f47f1 | 2025-06-04 | Warnings, Adverse reactions | 1652639 242120 GFX7QIS1II |
| PRISMASOL BGK2/0 | MAGNESIUM CHLORIDE, DEXTROSE ANHYDROUS, LACTIC ACID, SODIUM CHLORIDE, SODIUM BICARBONATE, AND POTASSIUM CHLORIDE | Vantive US Healthcare LLC | 7f675fee-8940-4ece-bb0c-75ac79d8708c | 2025-05-31 | Warnings, Adverse reactions | GR686LBA74 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.